DocSym
β
Searchsearch
Search
(Q86.1) Fetal hydantoin syndrome
More details coming soon
8 830 in individuals diagnosis fetal hydantoin syndrome confirmed
2 548 deaths with diagnosis fetal hydantoin syndrome
29% mortality rate associated with the disease fetal hydantoin syndrome
Diagnosis fetal hydantoin syndrome is diagnosed Women are 0.02% more likely than Men
4 414
Men receive the diagnosis fetal hydantoin syndrome
1 801 (40.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 416
Women receive the diagnosis fetal hydantoin syndrome
747 (16.9 %)Died from this diagnosis.
Risk Group for the Disease fetal hydantoin syndrome - Men and Women aged 0
In Men diagnosis is most often set at age 0-14, 20-24, 30-34, 55-64
Less common in men the disease occurs at Age 15-19, 25-29, 35-54, 65-95+Less common in women the disease occurs at Age 10-14, 25-95+
In Women diagnosis is most often set at age 0-9, 15-24
Disease Features fetal hydantoin syndrome
Absence or low individual and public risk
Fetal hydantoin syndrome - what does this mean
Fetal hydantoin syndrome is a rare disorder caused by a pregnant woman taking the anticonvulsant drug, hydantoin, during pregnancy. this drug interferes with the normal development of the fetus, causing physical and mental abnormalities, such as facial malformations, low birth weight, and intellectual disability.
What happens during the disease - fetal hydantoin syndrome
Fetal hydantoin syndrome is caused by in utero exposure to anticonvulsant medications, such as phenytoin, which disrupts normal fetal development due to its teratogenic effects. this disruption of normal development causes a range of physical and cognitive impairments, including craniofacial abnormalities, limb malformation, growth retardation, and intellectual disability.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical exam
- Detailed medical history
- Genetic testing
- Ultrasound
- Amniocentesis
- Chorionic villus sampling (CVS)
- Prenatal screening tests
- Blood tests
- Neurological evaluation
- Imaging studies (MRI, CT scan)
Treatment and Medical Assistance
Main Goal: Treat the symptoms of Fetal Hydantoin Syndrome
- Provide comprehensive physical and occupational therapy
- Provide speech, language, and hearing therapy
- Provide psychological and behavioral therapy
- Provide special education services
- Provide nutritional counseling and support
- Provide vision and hearing screening
- Provide medical monitoring and care
- Provide medications, such as anticonvulsants and muscle relaxants
- Provide genetic counseling and testing
- Provide family support and counseling
35 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Fetal hydantoin syndrome - Prevention
Fetal hydantoin syndrome can be prevented by avoiding the use of medications containing hydantoin derivatives during pregnancy. if a woman is taking these medications, she should consult her healthcare provider to discuss the risks and benefits of continuing them. additionally, women of childbearing age should practice safe contraception to avoid unintended pregnancies.